Lanthionine-related compounds for the treatment of inflammatory diseases

Details for Australian Patent Application No. 2007204757 (hide)

Owner Oklahoma Medical Research Foundation

Inventors Hensley, Kenneth

Agent Pizzeys

Pub. Number AU-B-2007204757

PCT Pub. Number WO2007/082208

Priority 60/757,252 09.01.06 US; 60/781,794 13.03.06 US; 60/804,149 07.06.06 US

Filing date 9 January 2007

Wipo publication date 19 July 2007

Acceptance publication date 6 September 2012

International Classifications

C07D 279/12 Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms

A61K 31/095 - Sulfur, selenium or tellurium compounds, e.g. thiols

A61K 31/132 - having two or more amino groups, e.g. spermidine, putrescine

A61K 31/54 - having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame

A61P 25/00 Drugs for disorders of the nervous system

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 Antineoplastic agents

Event Publications

14 August 2008 PCT application entered the National Phase

  PCT publication WO2007/082208 Priority application(s): WO2007/082208

6 September 2012 Application Accepted

  Published as AU-B-2007204757

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007204758-Fuel cell components having porous electrodes

2007204755-N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use